News

Medication is not a quick fix for obesity, Dr. Samuel L. Wilcox said during a "Lunch & Learn" session at the Iola Public ...
GLP-1 drugs like semaglutide and tirzepatide show promise in treating obesity, with benefits including weight loss and ...
India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, ...
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug on the market.
An injectable weight-loss treatment is now available through primary care across the UK - and general practices across ...
Eli Lilly receives approval for Mounjaro in prefilled Kwikpen as competition intensifies in India's weight-loss drug market ...
A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...
GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...
GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...
Signs of advanced chronic pancreatitis include weight loss, a loss of appetite, jaundice, other symptoms associated with ...
A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...
The once-monthly drug is still under study but could provide added convenience and another option for patients.